Vericel (VCEL) Non-Current Deffered Revenue (2016 - 2019)

Vericel's (VCEL) quarterly Non-Current Deffered Revenue came in at $134000.0 in Q2 2019, down 92.95% year-on-year from $1.9 million in Q2 2018, and down 92.95% quarter-over-quarter from $1.9 million in Q1 2019.

Vericel (VCEL) Non-Current Deffered Revenue (2016 - 2019) Analysis & Trends

Vericel has disclosed Non-Current Deffered Revenue across 4 years of filings, most recently posting $134000.0 for Q2 2019.

  • Non-Current Deffered Revenue for Q2 2019 came in at $134000.0, down 92.95% year-over-year; the trailing twelve-month figure through Jun 2019 was $134000.0 (down 92.95% YoY), and the FY2018 annual result was $1.7 million, down 19.09% from the prior year.
  • Non-Current Deffered Revenue came in at $134000.0 for Q2 2019 at Vericel, down from $1.9 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.1 million in Q4 2017 to a low of $134000.0 in Q2 2019.
  • The 4-year median for Non-Current Deffered Revenue is $1.7 million (2018), against an average of $1.5 million.
  • Across the five-year window, Non-Current Deffered Revenue jumped 111.11% in 2018 and tumbled 92.95% in 2019, its largest moves.
  • Vericel's Non-Current Deffered Revenue stood at $1.7 million in 2016, then gained by 22.05% to $2.1 million in 2017, then declined by 19.09% to $1.7 million in 2018, then plunged by 91.96% to $134000.0 in 2019.
  • The last three Non-Current Deffered Revenue figures came in at $134000.0 (Q2 2019), $1.9 million (Q1 2019), and $1.7 million (Q4 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 134,000.00
Mar 31, 2019 1.90 Mn
Dec 31, 2018 1.67 Mn
Sep 30, 2018 1.81 Mn
Jun 30, 2018 1.90 Mn
Mar 31, 2018 1.95 Mn
Dec 31, 2017 2.06 Mn
Sep 30, 2017 1.61 Mn
Jun 30, 2017 900,000.00
Mar 31, 2017 1.63 Mn
Dec 31, 2016 1.69 Mn
Sep 30, 2016 900,000.00
Jun 30, 2016 900,000.00